Genetics of Glycogen Storage Disease Type VI (Hers Disease) Medication

1. Ozen H. Glycogen storage diseases: new perspectives. World J Gastroenterol. May 2007. 13:2541-2553. [QxMD MEDLINE Link].

2. Hendriksz CJ, Gissen P. Glycogen storage disease. Paediatrics and Child health. 2015. 25 (3):139-144. [Full Text].

3. Hoogeveen IJ, van der Ende RM, van Spronsen FJ, de Boer F, Heiner-Fokkema MR, Derks TG. Normoglycemic Ketonemia as Biochemical Presentation in Ketotic Glycogen Storage Disease. JIMD Rep. 2016. 28:41-47. [QxMD MEDLINE Link]. [Full Text].

4. Weinstein DA, Steuerwald U, De Souza CFM, Derks TGJ. Inborn Errors of Metabolism with Hypoglycemia: Glycogen Storage Diseases and Inherited Disorders of Gluconeogenesis. Pediatr Clin North Am. 2018 Apr. 65 (2):247-265. [QxMD MEDLINE Link]. [Full Text].

5. Roscher A, Patel J, Hewson S, Nagy L, Feigenbaum A, Kronick J, et al. The natural history of glycogen storage disease types VI and IX: Long-term outcome from the largest metabolic center in Canada. Mol Genet Metab. 2014 Nov. 113 (3):171-6. [QxMD MEDLINE Link]. [Full Text].

6. Chang S, Rosenberg MJ, Morton H. Identification of a mutation in liver glycogen phosphorylase in glycogen storage disease type VI. Hum Mol Genet. 1998 May. 7(5):865-70. [QxMD MEDLINE Link].

7. Davit-Spraul A, Piraud M, Dobbelaere D, Valayannopoulos V, Labrune P, Habes D, et al. Liver glycogen storage diseases due to phosphorylase system deficiencies: diagnosis thanks to non invasive blood enzymatic and molecular studies. Mol Genet Metab. 2011 Sep-Oct. 104(1-2):137-43. [QxMD MEDLINE Link].

8. Burwinkel B, Bakker HD, Herschkovitz E. Mutations in the liver glycogen phosphorylase gene (PYGL) underlying glycogenosis type VI. Am J Hum Genet. 1998 Apr. 62(4):785-91. [QxMD MEDLINE Link].

9. Beauchamp NJ, Taybert J, Champion MP et al. High frequency of missense mutations in glycogen storage disease type VI. J Inherit Metab Dis. Oct 2007. 30:722-734. [QxMD MEDLINE Link].

10. Manzia TM, Angelico R, Toti L, et al. Glycogen storage disease type Ia and VI associated with hepatocellular carcinoma: two case reports. Transplant Proc. 2011 May. 43(4):1181-3. [QxMD MEDLINE Link].

11. Tang NL, Hui J, Young E, et al. A novel mutation (G233D) in the glycogen phosphorylase gene in a patient with hepatic glycogen storage disease and residual enzyme activity. Mol Genet Metab. 2003 Jun. 79(2):142-5. [QxMD MEDLINE Link].

12. Jagadisan B, Ranganath P. Glycogen Storage Disease Type VI With a Novel Mutation in PYGL Gene. Indian Pediatr. 2017 Sep 15. 54 (9):775-776. [QxMD MEDLINE Link]. [Full Text].

13. Price V, Didi M, Morris A, Senniappan S. Glycogen-storage disease type VI in a girl presenting with recurrent ketotic hypoglycaemia but no hepatomegaly. ESPE Abstracts. 2015. Available at http://abstracts.eurospe.org/hrp/0084/hrp0084p3-1065.htm.

14. Kotb MA, Abdallah HK, Kotb A. Liver glycogenoses: are they a possible cause of polyneuropathy? A cross-sectional study. J Trop Pediatr. 2004 Aug. 50(4):196-202. [QxMD MEDLINE Link].

15. Newgard CB, Fletterick RJ, Anderson LA. The polymorphic locus for glycogen storage disease VI (liver glycogen phosphorylase) maps to chromosome 14. Am J Hum Genet. 1987 Apr. 40(4):351-64. [QxMD MEDLINE Link].

16. Adeva-Andany MM, González-Lucán M, Donapetry-García C, Fernández-Fernández C, Ameneiros-Rodríguez E. Glycogen metabolism in humans. BBA Clin. 2016 Jun. 5:85-100. [QxMD MEDLINE Link]. [Full Text].

17. Goldberg T, Slonim AE. Nutrition therapy for hepatic glycogen storage diseases. J Am Diet Assoc. 1993 Dec. 93(12):1423-30. [QxMD MEDLINE Link].

18. Ross KM, Brown LM, Corrado MM, Chengsupanimit T, Curry LM, Ferrecchia IA, et al. Safety and efficacy of long-term use of extended release cornstarch therapy for glycogen storage disease types 0, III, VI, and IX. Journal of Nutritional Therapeutics. 2015. 4:137-142. [Full Text].

Anna V Blenda, PhD Clinical Associate Professor, Department of Biomedical Sciences, University of South Carolina School of Medicine, Greenville

Anna V Blenda, PhD is a member of the following medical societies: American Association for Cancer Research, American College of Medical Genetics and Genomics, American Society for Microbiology

Disclosure: Nothing to disclose.

Renee J Chosed, PhD Clinical Assistant Professor of Biochemistry, Department of Biomedical Sciences, University of South Carolina School of Medicine, Greenville

Renee J Chosed, PhD is a member of the following medical societies: American Society for Biochemistry and Molecular Biology, Association of Biochemistry Educators, Association of Professors of Human and Medical Genetics

Disclosure: Nothing to disclose.

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Maria Descartes, MD Professor, Department of Human Genetics and Department of Pediatrics, University of Alabama at Birmingham School of Medicine

Maria Descartes, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Medical Genetics and Genomics, American Medical Association, American Society of Human Genetics, Society for Inherited Metabolic Disorders, International Skeletal Dysplasia Society, Southeastern Regional Genetics Group

Disclosure: Nothing to disclose.

Edward Kaye, MD Vice President of Clinical Research, Genzyme Corporation

Edward Kaye, MD is a member of the following medical societies: American Academy of Neurology, Society for Inherited Metabolic Disorders, American Society of Gene and Cell Therapy, American Society of Human Genetics, Child Neurology Society

Disclosure: Received salary from Genzyme Corporation for management position.

Lynne Ierardi-Curto, MD, PhD Attending Physician, Division of Metabolism, Children's Hospital of Philadelphia

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article